[G2-PR11] Slot 11

[G2-PR11-07] Newly designed short-chain fatty acid-based self-assembling nanoparticle drugs for non-alcoholic steatohepatitis (NASH)

*Yuya Tajika¹, Babita Shashni¹, Yuji Nishikawa², Yukio Nagasaki¹ (1. Tsukuba Univ. (Japan), 2. Asahikawa Medical Univ. (Japan))

Keywords:nanoparticle-based therapy, short-chain fatty acids (SCFAs), non-alcoholic steatohepatitis (NASH), liver fibrosis, G-protein coupled receptor (GPCR)